BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7820611)

  • 1. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.
    Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN
    Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
    Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
    Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel medications for drug addiction. The legacy of an African shrub.
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antiaddictive actions of ibogaine.
    Glick SD; Maisonneuve IS
    Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.
    Pearl SM; Maisonneuve IM; Glick SD
    Neuropharmacology; 1996; 35(12):1779-84. PubMed ID: 9076757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine-like effects of noribogaine in rats.
    Glick SD; Pearl SM; Cai J; Maisonneuve IM
    Brain Res; 1996 Mar; 713(1-2):294-7. PubMed ID: 8725004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
    Maisonneuve IM; Glick SD
    Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
    Maisonneuve IM; Keller RW; Glick SD
    Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.
    Wei D; Maisonneuve IM; Kuehne ME; Glick SD
    Brain Res; 1998 Aug; 800(2):260-8. PubMed ID: 9685673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
    Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
    Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine.
    Glick SD; Rossman K; Wang S; Dong N; Keller RW
    Brain Res; 1993 Nov; 628(1-2):201-8. PubMed ID: 8313148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacological characterization of local ibogaine effects on dopamine release.
    Reid MS; Hsu K; Souza KH; Broderick PA; Berger SP
    J Neural Transm (Vienna); 1996; 103(8-9):967-85. PubMed ID: 9013390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and aftereffects of ibogaine on morphine self-administration in rats.
    Glick SD; Rossman K; Steindorf S; Maisonneuve IM; Carlson JN
    Eur J Pharmacol; 1991 Apr; 195(3):341-5. PubMed ID: 1868880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Antiaddictive Actions of Ibogaine
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 1998 May; 844(1):214-226. PubMed ID: 29090809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Nov; 847(1):139-42. PubMed ID: 10564747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons.
    French ED; Dillon K; Ali SF
    Life Sci; 1996; 59(12):PL199-205. PubMed ID: 8809219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.
    Fadda P; Scherma M; Fresu A; Collu M; Fratta W
    Synapse; 2003 Oct; 50(1):1-6. PubMed ID: 12872287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.